Paradoxical inflammation induced by anti-TNF agents in patients with IBD

Psoriasis Induced by Infliximab in a Patient Suffering from Crohn's Disease

(2017) E. Manni et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Alopecia Areata following Adalimumab

(2015) Carly Kirshen et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab

(2015) Penny Lovell English et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci

(2012) David Ellinghaus et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

(2012) Benjamin Ngo et al.   Current Molecular Pharmacology

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

(2011) G. Cullen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia

(2011) Leona A Doyle et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Pelade au cours d’un traitement par anti-TNF alpha : neuf cas

(2011) E. Le Bidre et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Skin Manifestations Induced by TNF-Alpha Inhibitors in Juvenile Idiopathic Arthritis

(2011) Irene Pontikaki et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus

(2011) Mariana Postal et al.   CYTOKINE

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

(2011) R. J. Erckens et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients

(2011) Daniel C. Baumgart et al.   INFLAMMATORY BOWEL DISEASES

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication

(2011) D. Tong et al.   INTERNAL MEDICINE JOURNAL

Infliximab-induced Psoriasis in Children With Inflammatory Bowel Disease

(2011) Girish Hiremath et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

(2011) Y. KOMANO et al.   JOURNAL OF RHEUMATOLOGY

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome

(2011) X. Baraliakos et al.   RHEUMATOLOGY

Histopathologic Spectrum of Psoriasiform Skin Reactions Associated With Tumor Necrosis Factor-α Inhibitor Therapy. A Study of 16 Biopsies

(2010) Alvaro C Laga et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease

(2010) Byung Cheol Park et al.   Annals of Dermatology

Psoriatic Skin Lesions Induced by Certolizumab Pegol

(2010) Rhonda Q. Klein et al.   ARCHIVES OF DERMATOLOGY

Sarcoidosis pulmonar inducida por antagonistas del factor de necrosis tumoral en la artritis reumatoide: presentación de un caso y revisión de la literatura médica

(2010) Laia Gifre et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Tumor necrosis factor α blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells

(2010) Hak-Ling Ma et al.   ARTHRITIS AND RHEUMATISM

Infliximab-Induced Psoriaform Rash

(2010) Jonathan Goldstein et al.   Clinical Gastroenterology and Hepatology

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

(2010) Jean–François Rahier et al.   Clinical Gastroenterology and Hepatology

Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association

(2010) Kristina Callis Duffin et al.   Dermatologic Therapy

Golimumab: a new anti-TNF-α agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

(2010) Paraskevi V Voulgari   Expert Review of Clinical Immunology

RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritis

(2010) Sofia Ramiro et al.   Expert Review of Clinical Immunology

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab

(2010) F. Medkour et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

(2010) Marisa Iborra et al.   Journal of Crohns & Colitis

Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents

(2010) M Ferran et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

(2010) Andre Franke et al.   NATURE GENETICS

Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease

(2010) Laurie S. Conklin et al.   Nature Reviews Gastroenterology & Hepatology

Occurrence of Pustular Psoriasis after Treatment of Crohn Disease with Infliximab

(2010) CRYSTAL POURCIAU et al.   PEDIATRIC DERMATOLOGY

Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis

(2010) Astrid Wiens et al.   PHARMACOTHERAPY

Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register

(2010) W. Kievit et al.   RHEUMATOLOGY

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety

(2010) P. J. Mease   RHEUMATOLOGY

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

(2009) Uwe Wollina et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis

(2009) J T Elder   GENES AND IMMUNITY

Tailoring the length of antiviral treatment for hepatitis C

(2009) A. Mangia et al.   GUT

Adalimumab safety in global clinical trials of patients with Crohnʼs disease

(2009) Jean-Frédéric Colombel et al.   INFLAMMATORY BOWEL DISEASES

Cutaneous vasculitis induced by TNF inhibitors: a report of three cases

(2009) Keita Fujikawa et al.   Modern Rheumatology

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis

(2009) Rafael de Cid et al.   NATURE GENETICS

Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

(2009) Rajan P Nair et al.   NATURE GENETICS

Alopecia Areata During Etanercept Therapy

(2009) Ying Pan et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors

(2009) SA Exarchou et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease

(2009) Frank Hoentjen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Vasculitis induced by tumor necrosis factor-targeted therapies

(2009) Manuel Ramos-Casals et al.   Current Rheumatology Reports

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

(2008) Angelique N. Collamer et al.   ARTHRITIS AND RHEUMATISM

Eczematous Dermatosis and Thrombocytosis Induced by Efalizumab: Two New Side Effects

(2008) D. Firmin et al.   DERMATOLOGY

Alopecia Areata Universalis Elicited during Treatment with Adalimumab

(2008) Nedzmidin Pelivani et al.   DERMATOLOGY

Alopecia Areata Universalis during Treatment of Rheumatoid Arthritis with Anti-TNF-α Antibody (Adalimumab)

(2008) Y. Chaves et al.   DERMATOLOGY

Genome-wide association scan in psoriasis: new insights into chronic inflammatory disease

(2008) Steven J Schrodi   Expert Review of Clinical Immunology

Detailed genetic characterization of the interleukin-23 receptor in psoriasis

(2008) V E Garcia et al.   GENES AND IMMUNITY

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

(2008) T Kobayashi et al.   GUT

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Guttate psoriasis induced by infliximab in a child with Crohnʼs disease

(2008) Marta Costa-Romero et al.   INFLAMMATORY BOWEL DISEASES

Tumour necrosis factor inhibitors in ankylosing spondylitis

(2008) M. R. Reed et al.   INTERNAL MEDICINE JOURNAL

Efalizumab‐induced guttate psoriasis. Successful management and re‐treatment

(2008) Anna Balato et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

(2008) Justin M. Ko et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

(2008) Jeffrey C Barrett et al.   NATURE GENETICS

A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci

(2008) Ying Liu et al.   PLoS Genetics

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

(2007) Julia Seiderer et al.   INFLAMMATORY BOWEL DISEASES

Palmoplantar and scalp psoriasis occurring during anti–tumour necrosis factor-α therapy: a case series of four patients and guidelines for management

(2007) E Papadavid et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY